What is Rybelsus?

Rybelsus (semaglutide) is the first oral GLP-1 receptor agonist approved to treat type 2 diabetes in adults. Unlike injectable alternatives, Rybelsus works as a daily pill that helps control blood sugar levels when combined with diet and exercise.

Key Benefits of Rybelsus

• Lowers A1C levels effectively
• Promotes weight loss in many patients
• Reduces cardiovascular risk
• Convenient oral medication (taken once daily)

How Rybelsus Works

Rybelsus works by mimicking the effects of GLP-1, a natural hormone that stimulates insulin production when blood sugar is high. It also slows stomach emptying, which helps control appetite and food intake.

Proper Usage Instructions

For best results:

• Take on an empty stomach when you first wake up
• Wait at least 30 minutes before you eat drink anything
• Swallow whole with a small sip of water (no crushing or splitting)
• Start with 3mg dose, increasing to 7mg or 14mg as directed

Common Side Effects of Rybelsus

While generally well-tolerated, some patients experience:

• Nausea stomach abdominal pain
• Diarrhea decreased appetite
• Vomiting and constipation
• Mild indigestion

These side effects of Rybelsus often diminish after several weeks of use. Risk may be higher if you use Rybelsus at maximum dosage.

Important Safety Information

Rybelsus may not be suitable if you have:

• History of medullary thyroid carcinoma
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Severe gastrointestinal disease
• Pancreatitis history

This medication carries a warning about thyroid C-cell tumors. Report any signs and diarrhea decreased appetite vomiting and constipation that persist.

Where to Buy Rybelsus

You can buy Rybelsus through:

• Licensed online pharmacies (with valid prescription)
• Local pharmacy chains
• Specialty diabetes medication providers

Always purchase from reputable sources to avoid counterfeit products.

Reporting Side Effects

Contact your healthcare provider immediately if you experience severe reactions. You may also visit www.fda.gov/medwatch or call 1-800-FDA-1088 to report adverse effects to the FDA.